Hemiplegic migraine requires a different treatment approach than typical migraine because the temporary motor weakness it causes overlaps with stroke symptoms, and several common migraine medications are considered unsafe for this subtype. Treatment focuses on preventing attacks with daily medication, managing acute episodes with non-vasoconstrictive pain relief, and knowing when an episode needs emergency evaluation.
Why Standard Migraine Drugs Are Off the Table
The first thing to understand about treating hemiplegic migraine is what you can’t use. Triptans, the most widely prescribed class of acute migraine medication, carry an FDA boxed warning about elevated risk of coronary and cerebrovascular events. They work partly by constricting blood vessels in the brain, which is the core concern. During a hemiplegic migraine attack, blood flow to parts of the brain is already dramatically reduced. One case study documented a 77% drop in cerebral blood flow across an entire hemisphere during the aura phase. Adding a drug that further constricts blood vessels on top of that creates a theoretical risk of pushing already-compromised brain tissue toward actual damage.
Ergotamines, an older class of migraine drugs, are excluded for the same reason: they also narrow blood vessels. This restriction shapes the entire treatment strategy and is why hemiplegic migraine often requires specialist management.
Acute Treatment During an Attack
When an attack hits, the options for stopping it are more limited than for regular migraine. Standard over-the-counter pain relievers like ibuprofen or naproxen are typically the first line for the headache pain itself. Anti-nausea medications can help if vomiting is part of the picture.
Some emergency departments use intravenous magnesium for severe migraine attacks, though the evidence for it is weak. A meta-analysis found no meaningful difference in pain reduction within 60 minutes compared to placebo, and patients who received IV magnesium experienced significantly more side effects, primarily flushing, dizziness, and burning at the injection site. It may still be tried in prolonged or severe cases when other options have failed, but it’s not a reliable rescue therapy.
Newer migraine drug classes that don’t constrict blood vessels, such as CGRP blockers (gepants) and ditans, are generating interest for hemiplegic migraine because they sidestep the vascular concerns that rule out triptans. However, clinical data specifically in hemiplegic migraine patients is still limited, and these medications are not yet part of formal treatment guidelines for this subtype. If your neurologist suggests trying one, it would be based on their clinical judgment rather than large-scale trial evidence.
Preventive Medications
Because acute treatment options are so restricted, prevention is the backbone of hemiplegic migraine management. The goal is reducing how often attacks happen and how severe they are. Two medications are specifically recommended for hemiplegic migraine prevention: lamotrigine and acetazolamide.
Lamotrigine is an anticonvulsant that appears to be particularly effective at reducing the aura component of hemiplegic migraine, including the motor weakness. It’s sometimes used in combination with valproic acid, another anticonvulsant, for both familial and sporadic forms of the condition. Lamotrigine requires a very slow dose increase over several weeks to avoid a rare but serious skin reaction, so don’t expect immediate results when starting it.
Acetazolamide works differently. It’s a mild diuretic that alters how the brain handles fluid and ion balance, which may stabilize the abnormal electrical wave (called cortical spreading depression) that triggers the aura and weakness. It’s used in both familial hemiplegic migraine and the sporadic form.
Flunarizine, a calcium channel blocker available in Europe but not the United States, is another preventive option for migraine generally. The recommended dose is 10 mg at night, though 5 mg appears equally effective with fewer side effects. For people over 65, only the lower dose is recommended. In children, the dose is 5 mg daily or every other day. Despite being a calcium channel blocker, it works differently from verapamil, which was tested in small studies and found to be largely ineffective for migraine prevention.
How Genetic Type May Affect Treatment
Familial hemiplegic migraine comes in at least three genetic subtypes, each caused by a mutation in a different gene affecting how nerve cells handle electrical signals. While no formal guidelines match specific medications to specific gene mutations, there’s some practical relevance. One case report of a family with the type 3 mutation (affecting a sodium channel gene) found that calcium channel blockers and triptans provided little improvement, and the treating team shifted to lamotrigine and acetazolamide instead.
Genetic testing isn’t required to start treatment, but if you have a confirmed familial form and your first preventive medication isn’t working, knowing your specific mutation type can help your neurologist narrow down alternatives more efficiently.
Telling an Attack Apart From a Stroke
One of the most stressful aspects of living with hemiplegic migraine is that every attack can look like a stroke: sudden one-sided weakness, sometimes speech difficulty, sometimes confusion. Even experienced emergency physicians find this challenging. Hemiplegic migraine is formally classified as a “stroke mimic,” and some attacks also cause fever, which can make them resemble a brain infection instead.
In the emergency department, CT imaging is usually done first to rule out bleeding in the brain. MRI is more useful for identifying the specific blood flow patterns associated with hemiplegic migraine: reduced perfusion on the affected side with changes in venous oxygen levels, rather than the blocked-vessel pattern seen in stroke. An EEG may show slow-wave activity across the affected hemisphere without the spike patterns typical of seizures.
If you’ve been diagnosed with hemiplegic migraine, carrying a letter from your neurologist that describes your typical attack pattern can speed up emergency triage. That said, you should still go to the ER if an attack feels different from your usual episodes, lasts significantly longer, or includes symptoms you haven’t experienced before. Having hemiplegic migraine does not make you immune to actual stroke.
Treatment in Children
Hemiplegic migraine can begin in childhood, and treatment looks somewhat different for younger patients. Flunarizine is dosed at 5 mg daily or every other day in children. Lamotrigine and acetazolamide are also used, with dosing adjusted by weight and age under specialist guidance.
The triptan question is more nuanced in pediatrics. While triptans are generally avoided in hemiplegic migraine, the American Academy of Neurology guidelines note that children and adolescents with hemiplegic migraine who don’t respond to first-line triptans should be referred to a headache specialist. This implies some clinicians do trial triptans in select pediatric cases, though it remains controversial. In the UK, oral sumatriptan is licensed for children over 6 and nasal sumatriptan for those over 12. Opioids have no evidence supporting their use in pediatric migraine of any type.
Building a Long-Term Management Plan
Hemiplegic migraine is a condition you manage over years, not something you fix with a single prescription. A practical plan typically involves three layers: a daily preventive medication (lamotrigine or acetazolamide as the starting point), a non-vasoconstrictive pain reliever for breakthrough attacks, and a clear action plan for when to go to the emergency department.
Tracking your attacks matters more with hemiplegic migraine than with regular migraine because the pattern of motor symptoms, their duration, and which side they affect gives your neurologist critical information for adjusting treatment. Many people find that their attacks have consistent triggers, such as stress, sleep disruption, or specific foods, and that avoiding triggers combined with preventive medication can dramatically reduce attack frequency even when no single intervention eliminates them completely.